In 2026, U.S. agreements lower costs of GLP-1 drugs for obesity and diabetes, impacting Medicare and Medicaid coverage with a focus on starter dose affordability and access limitations.

Aveanna Healthcare accelerates growth in home-based care through the acquisition of Thrive Skilled Pediatric Care, enhanced AI integration, and deep payer partnerships amid regulatory changes.

In 2025, Medicare Advantage insurers faced rising medical costs, regulatory challenges, and increased AI integration, leading to strategic service adjustments and market exits.

Study shows value-based payment models with two-sided risk improve clinical quality outcomes for Medicare Advantage beneficiaries compared to fee-for-service.